Abstract / Description of output
Despite greater certainty for biosimilar markets and regulation, the change that was seen in the small-molecule pharmaceuticals market with the rapid entrance of emerging-country generics suppliers will not be replicated exactly. The long game has yet to be played out, and recent changes in regulation, science, and production technology are likely to impact on future patterns of partnership and production.
Original language | English |
---|---|
Pages (from-to) | 250-252 |
Journal | Trends in biotechnology |
Volume | 33 |
Issue number | 5 |
Early online date | 20 Apr 2015 |
DOIs | |
Publication status | Published - May 2015 |
Keywords / Materials (for Non-textual outputs)
- biosimilar
- follow-on biologic
- subsequent entry biologic